Bayer, J&J’s heart drug Xarelto fails trial to widen use
FRANKFURT (Reuters) – Bayer and Johnson & Johnson’s campaign to widen the market for its heart drug Xarelto hit a snag on Sunday when a study for a potential new…
by October Gallery
FRANKFURT (Reuters) – Bayer and Johnson & Johnson’s campaign to widen the market for its heart drug Xarelto hit a snag on Sunday when a study for a potential new…